Skip to content
10-Q

Quarterly Report

Arbutus Biopharma Corp ABUS

0001447028-25-000126

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 192.32M sh
Shares Diluted Q3 2025 · Sep 30, 2025 191.78M sh
Shares Diluted Q3 2025 · Sep 30, 2025 191.35M sh
Shares Diluted Q3 2025 · Sep 30, 2024 189M sh
Shares Diluted Q3 2025 · Sep 30, 2024 184.24M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $96K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$34.96M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$54.54M
Long Term Debt Q3 2025 · Sep 30, 2025 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $22.41M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $36.33M
Stockholders Equity Q3 2025 · Sep 30, 2025 $77.4M
Stockholders Equity Q3 2025 · Jun 30, 2025 $82.98M
Stockholders Equity Q3 2025 · Mar 31, 2025 $79.16M
Stockholders Equity Q3 2025 · Dec 31, 2024 $97.37M
Stockholders Equity Q3 2025 · Sep 30, 2024 $106.89M
Stockholders Equity Q3 2025 · Jun 30, 2024 $122.45M
Stockholders Equity Q3 2025 · Mar 31, 2024 $114.64M
Stockholders Equity Q3 2025 · Dec 31, 2023 $106.02M
Current Liabilities Q3 2025 · Sep 30, 2025 $5.18M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.62M
Total Liabilities Q3 2025 · Sep 30, 2025 $20.31M
Total Liabilities Q3 2025 · Dec 31, 2024 $34.34M
Current Assets Q3 2025 · Sep 30, 2025 $97.44M
Current Assets Q3 2025 · Dec 31, 2024 $127.32M
Total Assets Q3 2025 · Sep 30, 2025 $97.71M
Total Assets Q3 2025 · Dec 31, 2024 $131.71M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.16
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.31
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.16
Eps Basic Q3 2025 · Sep 30, 2024 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.31
Sga Expense Q3 2025 · Sep 30, 2025 $3.04M
Sga Expense Q3 2025 · Sep 30, 2025 $12.2M
Sga Expense Q3 2025 · Sep 30, 2024 $4.54M
Sga Expense Q3 2025 · Sep 30, 2024 $17.4M
Rd Expense Q3 2025 · Sep 30, 2025 $5.78M
Rd Expense Q3 2025 · Sep 30, 2025 $20.24M
Rd Expense Q3 2025 · Sep 30, 2024 $14.27M
Rd Expense Q3 2025 · Sep 30, 2024 $45.23M
Net Income Q3 2025 · Sep 30, 2025 −$7.74M
Net Income Q3 2025 · Sep 30, 2025 −$29.75M
Net Income Q3 2025 · Jun 30, 2025 $2.52M
Net Income Q3 2025 · Mar 31, 2025 −$24.53M
Net Income Q3 2025 · Sep 30, 2024 −$19.72M
Net Income Q3 2025 · Sep 30, 2024 −$57.39M
Net Income Q3 2025 · Jun 30, 2024 −$19.8M
Net Income Q3 2025 · Mar 31, 2024 −$17.88M
Operating Income Q3 2025 · Sep 30, 2025 −$8.66M
Operating Income Q3 2025 · Sep 30, 2025 −$32.87M
Operating Income Q3 2025 · Sep 30, 2024 −$21.44M
Operating Income Q3 2025 · Sep 30, 2024 −$62.39M
Revenue Q3 2025 · Sep 30, 2025 $529K
Revenue Q3 2025 · Sep 30, 2025 $13.03M
Revenue Q3 2025 · Sep 30, 2024 $1.34M
Revenue Q3 2025 · Sep 30, 2024 $4.6M